Mr Chris Fotinopoulos

Infectious diseases

Videos

Update on recombinant zoster vaccine

In this Product Explainer, Infectious Diseases Physician and Clinical Virologist Prof Tony Cunningham AO provides an overview of the recombinant (ie non-live) Herpes Zoster vaccine including recent advances, efficacy and community effectiveness (7 mins).

Infectious diseases

Podcasts

Shingles vaccination in the immunocompromised – Which option for which patient?

Which immunocompromised patients should be given the recombinant (Shingrix) vs the inactivated (Zostavax)- different approaches to vaccination choice.

Immunology and allergy, Infectious diseases

Videos

Expanded indication for herpes zoster vaccine

In this Product Explainer, Prof Tony Cunningham AO will provide an update on the recombinant (ie non-live) Herpes Zoster vaccine including a practical explanation of which patients satisfy the “immunocompromised” criteria (7 mins).

Infectious diseases

Podcasts

Update on shingles vaccination – Lecture

Prof Tony Cunningham AO outlines all the latest evidence and information in relation to shingles

Infectious diseases

Videos

Herpes Zoster Vaccine

An important vaccine for Herpes Zoster prevention is available in Australia. Prof Cunningham AO will describe in practical detail the evidence for its effectiveness, safety profile, indications and contraindications and what advantages it has over other available options. (6 mins)

Infectious diseases

Podcasts

The new herpes zoster vaccine – Lecture

New and important vaccine for Herpes Zoster prevention is now available in Australia.

Sexual health

Monographs

Update on Herpes Zoster

This article discusses herpes zoster, the condition and its complications as well as the benefits, risks and challenges associated with the herpes zoster vaccine.

Mr Chris Fotinopoulos

More from this expert

Update on recombinant zoster vaccine

In this Product Explainer, Infectious Diseases Physician and Clinical Virologist Prof Tony Cunningham AO provides an overview of the recombinant (ie non-live) Herpes Zoster vaccine including recent advances, efficacy and community effectiveness (7 mins).

Shingles vaccination in the immunocompromised – Which option for which patient?

Which immunocompromised patients should be given the recombinant (Shingrix) vs the inactivated (Zostavax)- different approaches to vaccination choice.

Expanded indication for herpes zoster vaccine

In this Product Explainer, Prof Tony Cunningham AO will provide an update on the recombinant (ie non-live) Herpes Zoster vaccine including a practical explanation of which patients satisfy the “immunocompromised” criteria (7 mins).

Update on shingles vaccination – Lecture

Prof Tony Cunningham AO outlines all the latest evidence and information in relation to shingles

Herpes Zoster Vaccine

An important vaccine for Herpes Zoster prevention is available in Australia. Prof Cunningham AO will describe in practical detail the evidence for its effectiveness, safety profile, indications and contraindications and what advantages it has over other available options. (6 mins)

The new herpes zoster vaccine – Lecture

New and important vaccine for Herpes Zoster prevention is now available in Australia.

Update on Herpes Zoster

This article discusses herpes zoster, the condition and its complications as well as the benefits, risks and challenges associated with the herpes zoster vaccine.

Update on Herpes Zoster

This article discusses herpes zoster, the condition and its complications as well as the benefits, risks and challenges associated with the herpes zoster vaccine.

The new herpes zoster vaccine – Lecture

New and important vaccine for Herpes Zoster prevention is now available in Australia.

Herpes Zoster Vaccine

An important vaccine for Herpes Zoster prevention is available in Australia. Prof Cunningham AO will describe in practical detail the evidence for its effectiveness, safety profile, indications and contraindications and what advantages it has over other available options. (6 mins)

Update on shingles vaccination – Lecture

Prof Tony Cunningham AO outlines all the latest evidence and information in relation to shingles

Expanded indication for herpes zoster vaccine

In this Product Explainer, Prof Tony Cunningham AO will provide an update on the recombinant (ie non-live) Herpes Zoster vaccine including a practical explanation of which patients satisfy the “immunocompromised” criteria (7 mins).

Shingles vaccination in the immunocompromised – Which option for which patient?

Which immunocompromised patients should be given the recombinant (Shingrix) vs the inactivated (Zostavax)- different approaches to vaccination choice.

Update on recombinant zoster vaccine

In this Product Explainer, Infectious Diseases Physician and Clinical Virologist Prof Tony Cunningham AO provides an overview of the recombinant (ie non-live) Herpes Zoster vaccine including recent advances, efficacy and community effectiveness (7 mins).

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Mr Chris Fotinopoulos

More from this expert

In this Product Explainer, Infectious Diseases Physician and Clinical Virologist Prof Tony Cunningham AO provides an overview of the recombinant (ie non-live) Herpes Zoster vaccine including recent advances, efficacy and community effectiveness (7 mins).

Which immunocompromised patients should be given the recombinant (Shingrix) vs the inactivated (Zostavax)- different approaches to vaccination choice.

In this Product Explainer, Prof Tony Cunningham AO will provide an update on the recombinant (ie non-live) Herpes Zoster vaccine including a practical explanation of which patients satisfy the “immunocompromised” criteria (7 mins).

Prof Tony Cunningham AO outlines all the latest evidence and information in relation to shingles

An important vaccine for Herpes Zoster prevention is available in Australia. Prof Cunningham AO will describe in practical detail the evidence for its effectiveness, safety profile, indications and contraindications and what advantages it has over other available options. (6 mins)

New and important vaccine for Herpes Zoster prevention is now available in Australia.

This article discusses herpes zoster, the condition and its complications as well as the benefits, risks and challenges associated with the herpes zoster vaccine.

This article discusses herpes zoster, the condition and its complications as well as the benefits, risks and challenges associated with the herpes zoster vaccine.

New and important vaccine for Herpes Zoster prevention is now available in Australia.

An important vaccine for Herpes Zoster prevention is available in Australia. Prof Cunningham AO will describe in practical detail the evidence for its effectiveness, safety profile, indications and contraindications and what advantages it has over other available options. (6 mins)

Prof Tony Cunningham AO outlines all the latest evidence and information in relation to shingles

In this Product Explainer, Prof Tony Cunningham AO will provide an update on the recombinant (ie non-live) Herpes Zoster vaccine including a practical explanation of which patients satisfy the “immunocompromised” criteria (7 mins).

Which immunocompromised patients should be given the recombinant (Shingrix) vs the inactivated (Zostavax)- different approaches to vaccination choice.

In this Product Explainer, Infectious Diseases Physician and Clinical Virologist Prof Tony Cunningham AO provides an overview of the recombinant (ie non-live) Herpes Zoster vaccine including recent advances, efficacy and community effectiveness (7 mins).

Get the app

Site

Company

Connect

Legal

LOG IN FOR FULL ACCESS

SIGN UP FOR A FREE HEALTHED ACCOUNT

Extra Details

PASSWORD RESET

Discover

Healthed